Exhibit 99.1 IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance RESEARCH TRIANGLE PARK, N.C. February 6, 2025 – IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended December 31, 2024. "IQVIA delivered excellent fourth quarter performance, closing out a strong 2024," said Ari ...

IQVIA Holdings Inc. (IQV) will release its fourth-quarter 2024 results on Feb. 6, before market open.See Zacks Earnings Calendar to stay ahead of market-making news.IQV has an impressive earnings surprise history, having surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 1.7%.IQVIA Holdings Inc. Price, Consensus and EPS Surprise IQVIA’s Q4 ExpectationsThe Zacks Consensus Estimate for revenues is pegged at $3.9 billion, implying 1.4% growth from the year-ago quar ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as we ...

The upcoming report from IQVIA Holdings (IQV) is expected to reveal quarterly earnings of $3.11 per share, indicating an increase of 9.5% compared to the year-ago period. Analysts forecast revenues of $3.92 billion, representing an increase of 1.4% year over year.The consensus EPS estimate for the quarter has been revised 0.4% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Prior t ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Za ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? IQVIA Holdings (IQV) , which belongs to the Zacks Medical - Instruments industry, could be a great candidate to consider.This clinical testing company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 1.70%.For the most recent quarter, IQVIA was ...

IQVIA Holdings Inc. (IQV) is benefiting from its ability to standardize, organize and integrate data through analytics and global technology, which boosts its client base. Shareholder-friendly policy is another green flag for investors. Meanwhile, competitive pressure is troublesome and low liquidity poses a threat to the company’s ability to pay off short-term debt.IQV reported impressive third-quarter 2024 results. Adjusted earnings were $2.8 per share, outpacing the Zacks Consensus Estimate by 1.1% and r ...

IQVIA Holdings (IQV) shares rallied 3% in the last trading session to close at $197.27. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 3.1% loss over the past four weeks.The stock has recorded the price rise as the company’s short-cycle businesses continue to improve on the back of its clients’ launching drugs and executing critical commercial programs.This clinical testing company is expected to post quarte ...

Join Compounding Healthcare where we employ data analytics in combination with technical analysis and clinical data breakdown in order to manage a position in numerous potential multi-bagger investments that can grow into a comprehensive healthcare portfolio.It has been roughly 10 months from my previous article on IQVIA Holdings (NYSE: IQV ), where I discussed the company's Q4 2023 marks, which beat the Street's expectations thanks to record revenues and EPS growth. At that time, IQVIA publicizedHe is the ...

While IQVIA Holdings Inc. (IQV) benefits from its market leadership, data-driven innovation, and global expansion, it must navigate pricing pressure.IQV has an expected long-term (three to five years) EPS growth rate of 9.6%. The company’s earnings for 2024 and 2025 are expected to grow 9% and 6.9%, respectively.IQV’s Global Reach, Market Leadership in Healthcare AnalyticsIQVIA operates in over 100 countries, giving it a vast global footprint. This extensive presence enables it to tap into emerging markets ...